Usha Menon

40.1k total citations
305 papers, 10.6k citations indexed

About

Usha Menon is a scholar working on Reproductive Medicine, Oncology and Genetics. According to data from OpenAlex, Usha Menon has authored 305 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Reproductive Medicine, 100 papers in Oncology and 82 papers in Genetics. Recurrent topics in Usha Menon's work include Ovarian cancer diagnosis and treatment (124 papers), BRCA gene mutations in cancer (64 papers) and Global Cancer Incidence and Screening (54 papers). Usha Menon is often cited by papers focused on Ovarian cancer diagnosis and treatment (124 papers), BRCA gene mutations in cancer (64 papers) and Global Cancer Incidence and Screening (54 papers). Usha Menon collaborates with scholars based in United Kingdom, United States and Australia. Usha Menon's co-authors include Ian Jacobs, Aleksandra Gentry‐Maharaj, Victoria L. Champion, Celette Sugg Skinner, Steven J. Skates, Ranjit Manchanda, Andy Ryan, Matthew Burnell, Adam N. Rosenthal and John F. Timms and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Usha Menon

295 papers receiving 10.3k citations

Peers

Countries citing papers authored by Usha Menon

Since Specialization

Citations

This map shows the geographic impact of Usha Menon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Usha Menon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Usha Menon more than expected).

Fields of papers citing papers by Usha Menon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Usha Menon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Usha Menon. The network helps show where Usha Menon may publish in the future.

Co-authorship network of co-authors of Usha Menon

This figure shows the co-authorship network connecting the top 25 collaborators of Usha Menon. A scholar is included among the top collaborators of Usha Menon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Usha Menon. Usha Menon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Screening and prevention of ovarian cancer 2024 ·The Medical Journal of Australia ·Michail Sideris, Usha Menon, Ranjit Manchanda	37
2	Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer 2024 ·Journal of Obstetrics and Gynaecology ·Claire Newton, (unknown), Viola Liberale, Matthew Burnell, Usha Menon, Tim Mould, Adeola Olaitan, Nicola MacDonald, Martin Widschwendter, (unknown), Mary McCormack, Anita Mitra, Rupali Arora, Ranjit Manchanda	1
3	Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection 2024 ·PLoS Computational Biology ·Alexander Ney, (unknown), (unknown), Pilar Acedo, Oleg Blyuss, Harry J. Whitwell, Eithne Costello, Aleksandra Gentry‐Maharaj, Norman Williams, Usha Menon, Giuseppe Fusai, Alexey Zaikin, Stephen P. Pereira	0
4	Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer 2023 ·PROTEOMICS - CLINICAL APPLICATIONS ·Mriga Dutt, Günter Härtel, Renée S. Richards, Alok K. Shah, Ahmed Mohamed, Sophia Apostolidou, Aleksandra Gentry‐Maharaj, (unknown), John D. Hooper, Lewis Perrin, Usha Menon, Michelle M. Hill	5
5	Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India 2023 ·Cancers ·Divya Pillai, (unknown), Aleksandra Gentry‐Maharaj, Suryanarayana Deo, D. K. Vijaykumar, (unknown), Nitya Wadhwa, (unknown), (unknown), (unknown), Ravi Kannan, Zakir Husain, (unknown), Antonis C. Antoniou, Ranjit Manchanda, Usha Menon	3
6	Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter? 2023 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), (unknown), Usha Menon, Roman Gulati, Noel S. Weiss, Ruth Etzioni	3
7	Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews 2022 ·Diagnostics ·Faiza Gaba, (unknown), (unknown), Xin Yang, Dhivya Chandrasekaran, Jatinderpal Kalsi, Antonis C. Antoniou, Lucy Side, Saskia C. Sanderson, Jo Waller, Munaza Ahmed, Andrew J. Wallace, Yvonne Wallis, Usha Menon, Ian Jacobs, Rosa Legood, Dalya Marks, Ranjit Manchanda	5
8	Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes 2022 ·EBioMedicine ·Lucy Oldfield, A.G. Evans, (unknown), Claire Jenkinson, Tejpal Purewal, Eftychia Eirini Psarelli, Usha Menon, John F. Timms, Stephen P. Pereira, Paula Ghaneh, William Greenhalf, Christopher Halloran, Eithne Costello	23
9	Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women 2020 ·Cancers ·Aleksandra Gentry‐Maharaj, Oleg Blyuss, Andy Ryan, Matthew Burnell, Chloe Karpinskyj, Richard Gunu, Jatinderpal Kalsi, Anne Dawnay, Inés P. Mariño, Ranjit Manchanda, Karen H. Lu, Wei-Lei Yang, John F. Timms, Max Parmar, Steven J. Skates, Robert C. Bast, Ian Jacobs, Alexey Zaikin, Usha Menon	22
10	Human epididymis protein 4 antigen‐autoantibody complexes complement cancer antigen 125 for detecting early‐stage ovarian cancer 2019 ·Cancer ·(unknown), Zhen Lü, Jing Guo, Bryan Fellman, Jing Ning, Karen H. Lu, Usha Menon, Makoto Kobayashi, Samir Hanash, Joseph Celestino, Steven J. Skates, Robert C. Bast	23
11	Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population 2018 ·Clinical Cancer Research ·Oleg Blyuss, Matthew Burnell, Andy Ryan, Aleksandra Gentry‐Maharaj, Inés P. Mariño, Jatinderpal Kalsi, Ranjit Manchanda, John F. Timms, Mahesh Parmar, Steven J. Skates, Ian Jacobs, Alexey Zaikin, Usha Menon	39
12	Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer 2017 ·Clinical Cancer Research ·Wei-Lei Yang, Aleksandra Gentry‐Maharaj, (unknown), Andy Ryan, Evangelia Ourania Fourkala, Zhen Lü, Keith Baggerly, Yang Zhao, Karen H. Lu, David D.L. Bowtell, Ian Jacobs, Steven J. Skates, (unknown), Usha Menon, Robert C. Bast	44
13	Evidence of Altered Glycosylation of Serum Proteins Prior to Pancreatic Cancer Diagnosis 2017 ·International Journal of Molecular Sciences ·Shibu Krishnan, Harry J. Whitwell, (unknown), Aleksandra Gentry‐Maharaj, Usha Menon, Stephen P. Pereira, Marco Gaspari, John F. Timms	23
14	Population Distribution of Lifetime Risk of Ovarian Cancer in the United States 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Celeste Leigh Pearce, Daniel O. Stram, Roberta B. Ness, Douglas Stram, Lynda D. Roman, Claire Templeman, Alice W. Lee, Usha Menon, Peter A. Fasching, Jessica N. McAlpine, Jennifer A. Doherty, Francesmary Modugno, Joellen M. Schildkraut, Mary Anne Rossing, David G. Huntsman, Anna H. Wu, Andrew Berchuck, Malcolm C. Pike, Paul D.P. Pharoah	71
15	Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection 2014 ·Clinical Cancer Research ·Darragh P. O’Brien, Neomal S. Sandanayake, Claire Jenkinson, Aleksandra Gentry‐Maharaj, Sophia Apostolidou, Evangelia‐Ourania Fourkala, Stéphane Camuzeaux, Oleg Blyuss, Richard Gunu, Anne Dawnay, Alexey Zaikin, Ross C. Smith, Ian Jacobs, Usha Menon, Eithne Costello, Stephen P. Pereira, John F. Timms	147
16	Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer 2014 ·Journal of Proteomics ·C Jenkinson, Victoria A. Elliott, Usha Menon, Sophia Apostolidou, (unknown), Aleksandra Gentry‐Maharaj, Stephen P. Pereira, Ian Jacobs, Trevor F. Cox, William Greenhalf, John F. Timms, Robert Sutton, John P. Neoptolemos, Eithne Costello	34
17	Population based testing for high-penetrance dominant gene mutations: initial results from the pilot phase of GCaPPS 2012 ·UCL Discovery (University College London) ·Ranjit Manchanda, K Loggenberg, Sue Gessler, Saskia C. Sanderson, (unknown), Jon Wardle, Ian Tomlinson, Amy L. McGuire, Uziel Beller, Lucy Side, Usha Menon, Ian Jacobs	2
18	The value of ovarian cancer screening 2006 ·British Journal of Hospital Medicine ·Aarti Sharma, Usha Menon	1
19	Development and identification of tumour markers. 2005 ·UCL Discovery (University College London) ·Kimberly A. Reynolds, Usha Menon, Ian Jacobs	1
20	Factors influencing serum CA125II levels in healthy postmenopausal women. 2001 ·PubMed ·Donna K. Pauler, Usha Menon, Martin McIntosh, Heather Symecko, Steven J. Skates, Ian Jacobs	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact